个人中心 - 老虎社区

Mglay

IP属地：未知

帖子 · 4帖子 · 4
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- MglayMglay
  ·2021-07-20
  Like
  The SPY Bears Look Strong, But Bulls Have Opportunity
  The SPDR S&P 500 ETF (NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on F
  The SPY Bears Look Strong, But Bulls Have Opportunity
  240 评论
  点赞
  分享
  举报
- MglayMglay
  ·2021-07-20
  Like
  BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum
  BioNTech SE is buying a cell therapy R&D platform plus a manufacturing site from Gilead Science Inc'
  BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum
  318 评论
  2
  分享
  举报
- MglayMglay
  ·2021-07-20
  Like
  非常抱歉，此主贴已删除
  331 评论
  点赞
  分享
  举报
- MglayMglay
  ·2021-07-20
  like
  非常抱歉，此主贴已删除
  440 评论
  点赞
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4089823128713960","uuid":"4089823128713960","gmtCreate":1626720065560,"gmtModify":1626750300837,"name":"Mglay","pinyin":"mglay","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":171151445,"gmtCreate":1626722997187,"gmtModify":1633924671069,"author":{"id":"4089823128713960","authorId":"4089823128713960","name":"Mglay","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089823128713960","authorIdStr":"4089823128713960"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171151445","repostId":"1157946065","repostType":4,"repost":{"id":"1157946065","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626709024,"share":"https://www.laohu8.com/m/news/1157946065?lang=&edition=full","pubTime":"2021-07-19 23:37","market":"us","language":"en","title":"The SPY Bears Look Strong, But Bulls Have Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1157946065","media":"Benzinga","summary":"The SPDR S&P 500 ETF (NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on F","content":"<p><b>The SPDR S&amp;P 500 ETF</b>&nbsp;(NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on Friday. The sell-off is being attributed to the increased spread of the COVID-19 Delta variant and inflation fears but the dip could provide opportunities for bullish traders.</p>\n<p>On Friday, options traders seemed to forecast a gap down on Monday morning and purchased over $9.12 million worth of bearish SPY put contracts. A number of traders purchased puts with a strike price of $430 with an expiry of July 21 which opened \"in-the-money.\"</p>\n<p>Big tech earnings kick off this week with&nbsp;<b>Netflix Inc</b>(NASDAQ:NFLX) reporting Tuesday afternoon and the dip could provide a strong buying opportunity if the streaming company beats expectations. The spread of the Delta variant could also cause the Federal Reserve to pause its talk of tapering, which would be a good sign for the bulls going forward into the third quarter and beyond.</p>\n<p>For technical traders, regardless of the narrative around the recent pullback, the SPY has key levels to watch.</p>\n<p><b>The SPY Chart:</b>&nbsp;The SPY created a bearish double top pattern when it hit a new all-time high of $437.92 on Tuesday and Wednesday of last week. On Friday, the SPY printed a bearish engulfing candlestick pattern indicating lower prices were in the cards for Monday. An engulfing candlestick pattern is recognized by a candle that fully eclipses the previous smaller candlestick and has little or no upper or lower wick.</p>\n<p>On Monday morning the SPY opened just above a key support zone at the $425 mark, tested the level as support and bounced. The SPY has another support level just below at $422.82 that may provide support if the SPY loses the $425 level.</p>\n<p>The SPY is trading below both the eight-day and 21-day exponential moving averages (EMAs), which is bearish, but the eight-day EMA is trending above the 21-day EMA, which is bullish. This indicates indecision in the short term. The SPY is trading well above the 200-day simple moving average, which indicates overall sentiment remains bullish for the longer-term outlook.</p>\n<p><img src=\"https://static.tigerbbs.com/0776e35fc3dd381ce4bc6db6f84308c4\" tg-width=\"1366\" tg-height=\"768\" width=\"100%\" height=\"auto\">There is support below at $425.77, $422.82, $417.81 and $412. The SPY has psychological support at $400 although the level has yet to be tested by price action.</p>\n<p><b>SPY Price Action:</b>The SPDR S&amp;P 500 was trading down.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The SPY Bears Look Strong, But Bulls Have Opportunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe SPY Bears Look Strong, But Bulls Have Opportunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-19 23:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>The SPDR S&amp;P 500 ETF</b>&nbsp;(NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on Friday. The sell-off is being attributed to the increased spread of the COVID-19 Delta variant and inflation fears but the dip could provide opportunities for bullish traders.</p>\n<p>On Friday, options traders seemed to forecast a gap down on Monday morning and purchased over $9.12 million worth of bearish SPY put contracts. A number of traders purchased puts with a strike price of $430 with an expiry of July 21 which opened \"in-the-money.\"</p>\n<p>Big tech earnings kick off this week with&nbsp;<b>Netflix Inc</b>(NASDAQ:NFLX) reporting Tuesday afternoon and the dip could provide a strong buying opportunity if the streaming company beats expectations. The spread of the Delta variant could also cause the Federal Reserve to pause its talk of tapering, which would be a good sign for the bulls going forward into the third quarter and beyond.</p>\n<p>For technical traders, regardless of the narrative around the recent pullback, the SPY has key levels to watch.</p>\n<p><b>The SPY Chart:</b>&nbsp;The SPY created a bearish double top pattern when it hit a new all-time high of $437.92 on Tuesday and Wednesday of last week. On Friday, the SPY printed a bearish engulfing candlestick pattern indicating lower prices were in the cards for Monday. An engulfing candlestick pattern is recognized by a candle that fully eclipses the previous smaller candlestick and has little or no upper or lower wick.</p>\n<p>On Monday morning the SPY opened just above a key support zone at the $425 mark, tested the level as support and bounced. The SPY has another support level just below at $422.82 that may provide support if the SPY loses the $425 level.</p>\n<p>The SPY is trading below both the eight-day and 21-day exponential moving averages (EMAs), which is bearish, but the eight-day EMA is trending above the 21-day EMA, which is bullish. This indicates indecision in the short term. The SPY is trading well above the 200-day simple moving average, which indicates overall sentiment remains bullish for the longer-term outlook.</p>\n<p><img src=\"https://static.tigerbbs.com/0776e35fc3dd381ce4bc6db6f84308c4\" tg-width=\"1366\" tg-height=\"768\" width=\"100%\" height=\"auto\">There is support below at $425.77, $422.82, $417.81 and $412. The SPY has psychological support at $400 although the level has yet to be tested by price action.</p>\n<p><b>SPY Price Action:</b>The SPDR S&amp;P 500 was trading down.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157946065","content_text":"The SPDR S&P 500 ETF (NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on Friday. The sell-off is being attributed to the increased spread of the COVID-19 Delta variant and inflation fears but the dip could provide opportunities for bullish traders.\nOn Friday, options traders seemed to forecast a gap down on Monday morning and purchased over $9.12 million worth of bearish SPY put contracts. A number of traders purchased puts with a strike price of $430 with an expiry of July 21 which opened \"in-the-money.\"\nBig tech earnings kick off this week with Netflix Inc(NASDAQ:NFLX) reporting Tuesday afternoon and the dip could provide a strong buying opportunity if the streaming company beats expectations. The spread of the Delta variant could also cause the Federal Reserve to pause its talk of tapering, which would be a good sign for the bulls going forward into the third quarter and beyond.\nFor technical traders, regardless of the narrative around the recent pullback, the SPY has key levels to watch.\nThe SPY Chart: The SPY created a bearish double top pattern when it hit a new all-time high of $437.92 on Tuesday and Wednesday of last week. On Friday, the SPY printed a bearish engulfing candlestick pattern indicating lower prices were in the cards for Monday. An engulfing candlestick pattern is recognized by a candle that fully eclipses the previous smaller candlestick and has little or no upper or lower wick.\nOn Monday morning the SPY opened just above a key support zone at the $425 mark, tested the level as support and bounced. The SPY has another support level just below at $422.82 that may provide support if the SPY loses the $425 level.\nThe SPY is trading below both the eight-day and 21-day exponential moving averages (EMAs), which is bearish, but the eight-day EMA is trending above the 21-day EMA, which is bullish. This indicates indecision in the short term. The SPY is trading well above the 200-day simple moving average, which indicates overall sentiment remains bullish for the longer-term outlook.\nThere is support below at $425.77, $422.82, $417.81 and $412. The SPY has psychological support at $400 although the level has yet to be tested by price action.\nSPY Price Action:The SPDR S&P 500 was trading down.","news_type":1},"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171151505,"gmtCreate":1626722986407,"gmtModify":1633924671191,"author":{"id":"4089823128713960","authorId":"4089823128713960","name":"Mglay","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089823128713960","authorIdStr":"4089823128713960"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171151505","repostId":"1160801924","repostType":4,"repost":{"id":"1160801924","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626709874,"share":"https://www.laohu8.com/m/news/1160801924?lang=&edition=full","pubTime":"2021-07-19 23:51","market":"us","language":"en","title":"BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum","url":"https://stock-news.laohu8.com/highlight/detail?id=1160801924","media":"Benzinga","summary":"BioNTech SE is buying a cell therapy R&D platform plus a manufacturing site from Gilead Science Inc'","content":"<p><b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>&nbsp;is&nbsp;buying a cell therapy R&amp;D platform plus a manufacturing site&nbsp;from&nbsp;<b>Gilead Science Inc's</b>GILD 0.91%Kite subsidiary.</p>\n<p>The deal gives BioNTech Kite's R&amp;D IP for its personalized solid tumor neoantigen T cell receptor (TCR) work and the manufacturing center in Gaithersburg, MD, which supplies the clinical trial product.</p>\n<p>This program builds and further extends BioNTech's leadership in individualized neoantigen targeting programs such as BNT122 (iNeST) and BNT221 (NEOSTIM).</p>\n<p>The acquired Gaithersburg facility will provide production capacity to support clinical trials in the U.S. and complement BioNTech's existing cell therapy manufacturing facility in Germany.</p>\n<p>Financial terms were not disclosed.</p>\n<p>Kite's new manufacturing facility in Frederick, MD, for commercial production of CAR T-cell therapy is not part of the purchase agreement.</p>\n<p><b>Price Action:</b>&nbsp;BNTX shares are up 0.86% at $233.46 during the market session on the last check Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-19 23:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>&nbsp;is&nbsp;buying a cell therapy R&amp;D platform plus a manufacturing site&nbsp;from&nbsp;<b>Gilead Science Inc's</b>GILD 0.91%Kite subsidiary.</p>\n<p>The deal gives BioNTech Kite's R&amp;D IP for its personalized solid tumor neoantigen T cell receptor (TCR) work and the manufacturing center in Gaithersburg, MD, which supplies the clinical trial product.</p>\n<p>This program builds and further extends BioNTech's leadership in individualized neoantigen targeting programs such as BNT122 (iNeST) and BNT221 (NEOSTIM).</p>\n<p>The acquired Gaithersburg facility will provide production capacity to support clinical trials in the U.S. and complement BioNTech's existing cell therapy manufacturing facility in Germany.</p>\n<p>Financial terms were not disclosed.</p>\n<p>Kite's new manufacturing facility in Frederick, MD, for commercial production of CAR T-cell therapy is not part of the purchase agreement.</p>\n<p><b>Price Action:</b>&nbsp;BNTX shares are up 0.86% at $233.46 during the market session on the last check Monday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GILD":"吉利德科学","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160801924","content_text":"BioNTech SE is buying a cell therapy R&D platform plus a manufacturing site from Gilead Science Inc'sGILD 0.91%Kite subsidiary.\nThe deal gives BioNTech Kite's R&D IP for its personalized solid tumor neoantigen T cell receptor (TCR) work and the manufacturing center in Gaithersburg, MD, which supplies the clinical trial product.\nThis program builds and further extends BioNTech's leadership in individualized neoantigen targeting programs such as BNT122 (iNeST) and BNT221 (NEOSTIM).\nThe acquired Gaithersburg facility will provide production capacity to support clinical trials in the U.S. and complement BioNTech's existing cell therapy manufacturing facility in Germany.\nFinancial terms were not disclosed.\nKite's new manufacturing facility in Frederick, MD, for commercial production of CAR T-cell therapy is not part of the purchase agreement.\nPrice Action: BNTX shares are up 0.86% at $233.46 during the market session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171151222,"gmtCreate":1626722963366,"gmtModify":1633924671313,"author":{"id":"4089823128713960","authorId":"4089823128713960","name":"Mglay","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089823128713960","authorIdStr":"4089823128713960"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171151222","repostId":"1111084715","repostType":4,"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171150991,"gmtCreate":1626721089313,"gmtModify":1633924673795,"author":{"id":"4089823128713960","authorId":"4089823128713960","name":"Mglay","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089823128713960","authorIdStr":"4089823128713960"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171150991","repostId":"2152827296","repostType":4,"isVote":1,"tweetType":1,"viewCount":440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":false}